New trends in first-line treatment of non-small cell lung cancer: combinations without platinum.

New trends in first-line treatment of non-small cell lung cancer: combinations without platinum. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

New trends in first-line treatment of non-small cell lung cancer: combinations without platinum. Abstract Text:

Emilio Esteban ,

New trends in first-line treatment of non-small cell lung cancer: combinations without platinum. Publishing Authors By Initials

EE ,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

New trends in first-line treatment of non-small cell lung cancer: combinations without platinum. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Current oncology reports

VOLUME: 6 Suppl 1

Page Numbers: S18-9

Journal Abbreviation:

ISSN: 1534-6269

DAY: 17

MONTH: Dec

YEAR: 2004

New trends in first-line treatment of non-small cell lung cancer: combinations without platinum. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100888967

New trends in first-line treatment of non-small cell lung cancer: combinations without platinum. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: New trends in first-line treatment of non-small cell lung cancer: combinations without platinum. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for New trends in first-line treatment of non-small cell lung cancer: combinations without platinum.

AFFILIATION: Servicio de Oncología Médica. Hospital Central de Asturias, Julian Clavería S/N, 33006, Oviedo. Asturias, Spain.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Curr Oncol Rep

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

New trends in first-line treatment of non-small cell lung cancer: combinations without platinum Related Publications

• A Family-Based Intervention Strategy for Addressing Childhood Obesity in an At-Risk Population: 1354: Board #117 May 30 9:30 AM - 11:00 AM.
• Adaptive model of the gradient index of the human lens. I. Formulation and model of aging ex vivo lenses.
• Beach morphodynamics forcements in oiled shorelines: Coupled physical and chemical processes during and after fuel burial.
• Biological research on drug abuse and addiction in Hispanics: current status and future directions.
• Citrate metabolism by Enterococcus faecium and Enterococcus durans isolated from goat's and ewe's milk: influence of glucose and lactose.
• Disease evolution of patients with mycosis fungoides--a report of 30 cases.
• Evaluation of the quality of the water in El Hondo natural park located in the east of Spain.
• Evolution of the amygdaloid complex in vertebrates, with special reference to the anamnio-amniotic transition.
• Genetic characterization of 2,4,6-trichlorophenol degradation in Cupriavidus necator JMP134.
• Human infection by Angiostrongylus costaricensis in Venezuela: first report of a confirmed case.
• Identification of ethanol responsive domains of adenylyl cyclase.
• Inbreeding and Reproduction in Endangered Ungulates: Preservation of Genetic Variation through the Organization of Genetic Resource Banks.
• Involvement of specific laminins and nidogens in the active remodeling of the basal lamina of labial salivary glands from patients with Sjögren's syndrome.
• Metabolomic and genetic analysis of biomarkers for peroxisome proliferator-activated receptor alpha expression and activation.
• Mouse lung CYP1A1 catalyzes the metabolic activation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
• New trends in first-line treatment of non-small cell lung cancer: combinations without platinum.
• Noninvasive evaluation of allergic and irritant contact dermatitis by in vivo reflectance confocal microscopy.
• P2Y2 receptors induced cell surface redistribution of alpha(v) integrin is required for activation of ERK 1/2 in U937 cells.
• Parathyroid hormone assay: problems and opportunities.
• Pathology findings and validation of gastric and esophageal cancer cases in a European cohort (EPIC/EUR-GAST).
• Pharmacological study of uzarigenin-glucoside-canaroside.
• Phosphodiesterase type 5 inhibitors for the treatment of male lower urinary tract symptoms.
• Polymorphism in the 3' UTR of the IL12B gene is associated with Chagas' disease cardiomyopathy.
• Rehabilitation and recovery in schizophrenia.
• Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice.
• Src and Pyk2 mediate angiotensin II effects in cultured rat astrocytes.
• The PREgnane X receptor gene-humanized mouse: a model for investigating drug-drug interactions mediated by cytochromes P450 3A.
• [Caffeine inhibits chemoreceptor responses to hypoxia.]
• [Effects of the implementation of Universal Access with Explicit Guaranties (AUGE) Plan on the quality of care of patients with terminal renal failure]
• [Moonlighting physicians: analysis of its causes and consequences.]